Dr. Joseph McGuirk, DO – Kansas City, KS

Joseph McGuirk, DO, has been a principal investigator in more than 49 clinical trials and has authored or co-authored more than 300 publications, abstracts, oral presentations and posters. He has presented at dozens of universities and associations, including Dana-Farber Cancer Center and Beth Israel Hospital in Boston, the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, the American Society of Hematology Annual Meeting,
the Kansas Association of Osteopathic Medicine, AABB (American Association of Blood Banks) and AACR (American Association for Cancer Research). He is also a member of numerous cancer center committees, including blood utilization, multidisciplinary cancer, graft sources, infection prevention and hematology/BMT disease working
groups and is the Chair for RITN Working Committee, KC Round Table of Hematology and Oncology, and Cancer Pharmacy and Therapeutics.

Dr. McGuirk completed his residency at Yale and his fellowship training at Memorial Sloan-Kettering Cancer Center in New York City and subsequently served as Associate Director of the Yale Stem Cell Transplant Program. He served as medical director of Kansas City Cancer Center’s blood and marrow transplant program at St. Luke’s Hospital before joining The University of Kansas Cancer Center in 2007. He currently serves as Director for the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Cancer Center and holds the endowed Schutte-Speas Professorship in Hematology-Oncology. Also, he currently serves on the ASTCT Board of Directors as a Director and Chairs the AACI National CAR-T initiative.

He is currently serving on over 25 national journals on Advisory Boards and Editorial Boards. He has been invited to present, Co-Chair, and Chair all over the United States and Internationally in Russia, China, and Switzerland and his publications have been presented internationally, nationally, and locally.